There has been recent warnings about eating dairy products like cheese due to the ongoing spread of GB syndrome.
In the uncommon neurological condition known as Guillain-Barré Syndrome, the body's immune system targets the peripheral nerves.
GBS has been linked to certain viral infections, including the flu and, more recently, COVID-19, causing a rise in cases in some regions.
Muscle weakness, tingling, and numbness are among the early symptoms, which frequently begin in the legs and move higher.
GBS typically progresses rapidly over a few days or weeks, sometimes leading to paralysis.
In extreme situations, it may impair breathing, resulting in respiratory failure that necessitates medical assistance.
Physical examinations, nerve conduction investigations, and lumbar punctures (CSF analysis) are used to diagnose GBS.
Intravenous immunoglobulin (IVIG) or plasmapheresis (plasma exchange) are frequently used in treatment to lessen the immune system's assault on nerves.
Hospitalization is necessary in severe cases to address symptoms, including keeping an eye on heart and breathing patterns.
It may take weeks or months to recover. While some people may suffer from long-term weakness, most people get better with time.
Although it is uncommon, the mortality rate is low (about 3-7%), though it varies depending on the severity of the disease and whether respiratory failure develops.
Maintaining proper hygiene is crucial to lowering the risk of GBS and preventing infections, particularly during flu season.
By avoiding the underlying diseases, vaccinations against COVID-19 and the flu can lower the risk of developing GBS.
Although GBS can strike anyone at any age, it most frequently affects men and adults. Significant risk factors include prior bacterial or viral infections.